Cempra Presents Late-Breaker on Solithromycin’s Anti NASH Effects in an Animal Model at DDW 2014

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc., today announced a late-breaker presentation demonstrating that solithromycin significantly reduced ballooning degeneration and inflammation which are histological signs … more

View todays social media effects on CEMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Cempra is hiring next, click here to view